# reload+after+2024-01-22 02:43:16.150546
address1§100 Campus Drive
address2§6th Floor
city§Marlborough
state§MA
zip§01752
country§United States
phone§855 896 8401
fax§855 404 0061
website§https://www.akoyabio.com
industry§Medical Instruments & Supplies
sector§Healthcare
longBusinessSummary§Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
fullTimeEmployees§369
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Brian  McKelligon', 'age': 54, 'title': 'President, CEO & Director', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 1147943, 'exercisedValue': 0, 'unexercisedValue': 7248470}, {'maxAge': 1, 'name': 'Dr. Garry P. Nolan Ph.D.', 'age': 61, 'title': 'Co-Founder, Independent Director & Head of the Scientific Advisory Board', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 48750, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nikolay  Samusik Ph.D.', 'title': 'Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Yury  Goltsev Ph.D.', 'title': 'Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John Frederick Ek', 'age': 47, 'title': 'CFO, Principal Financial Officer & Principal Accounting Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Frederic G. Pla Ph.D.', 'age': 64, 'title': 'Chief Operating Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 445271, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Priyam  Shah', 'title': 'Senior Director of Business Development & Investor Relations Strategy', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Kamocsay', 'age': 52, 'title': 'General Counsel', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Paul  Grass', 'title': 'Senior Vice President of Sales', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Niro  Ramachandran Ph.D.', 'age': 48, 'title': 'Chief Business Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 298181, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§5
boardRisk§9
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.472
priceToSalesTrailing12Months§2.3258352
currency§USD
dateShortInterest§1702598400
forwardEps§-0.93
exchange§NMS
quoteType§EQUITY
shortName§Akoya BioSciences, Inc.
longName§Akoya Biosciences, Inc.
firstTradeDateEpochUtc§1618579800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§eb3df861-adbf-3878-b6cb-be19fbedde1b
gmtOffSetMilliseconds§-18000000
targetHighPrice§12.0
targetLowPrice§7.0
targetMeanPrice§9.25
targetMedianPrice§9.0
recommendationMean§1.9
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§2.666
grossMargins§0.5662
ebitdaMargins§-0.60876
trailingPegRatio§None
